Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
SMART-lipid nanoparticles enabled mRNA vaccine elicits cross-reactive humoral responses against the omicron sub-variants.
Mol Ther. 2024 May 1;32(5):1284-1297. doi: 10.1016/j.ymthe.2024.02.028. Epub 2024 Feb 27.
Mol Ther. 2024.
PMID: 38414245
Current approaches and potential challenges in the delivery of gene editing cargos into hematopoietic stem and progenitor cells.
Murugesan R, Karuppusamy KV, Marepally S, Thangavel S.
Murugesan R, et al. Among authors: karuppusamy kv.
Front Genome Ed. 2023 Sep 15;5:1148693. doi: 10.3389/fgeed.2023.1148693. eCollection 2023.
Front Genome Ed. 2023.
PMID: 37780116
Free PMC article.
Review.
Item in Clipboard
Editing the core region in HPFH deletions alters fetal and adult globin expression for treatment of β-hemoglobinopathies.
Venkatesan V, Christopher AC, Rhiel M, Azhagiri MKK, Babu P, Walavalkar K, Saravanan B, Andrieux G, Rangaraj S, Srinivasan S, Karuppusamy KV, Jacob A, Bagchi A, Pai AA, Nakamura Y, Kurita R, Balasubramanian P, Pai R, Marepally SK, Mohankumar KM, Velayudhan SR, Boerries M, Notani D, Cathomen T, Srivastava A, Thangavel S.
Venkatesan V, et al. Among authors: karuppusamy kv.
Mol Ther Nucleic Acids. 2023 Apr 26;32:671-688. doi: 10.1016/j.omtn.2023.04.024. eCollection 2023 Jun 13.
Mol Ther Nucleic Acids. 2023.
PMID: 37215154
Free PMC article.
Item in Clipboard
CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications.
Venkatesan V, Christopher AC, Karuppusamy KV, Babu P, Alagiri MKK, Thangavel S.
Venkatesan V, et al. Among authors: karuppusamy kv.
J Vis Exp. 2022 Aug 9;(186). doi: 10.3791/64064.
J Vis Exp. 2022.
PMID: 36036597
Item in Clipboard
The CCR5 Gene Edited CD34+CD90+ Hematopoietic Stem Cell Population Serves as an Optimal Graft Source for HIV Gene Therapy.
Karuppusamy KV, Demosthenes JP, Venkatesan V, Christopher AC, Babu P, Azhagiri MK, Jacob A, Ramalingam VV, Rangaraj S, Murugesan MK, Marepally SK, Varghese GM, Srivastava A, Kannangai R, Thangavel S.
Karuppusamy KV, et al.
Front Immunol. 2022 Mar 14;13:792684. doi: 10.3389/fimmu.2022.792684. eCollection 2022.
Front Immunol. 2022.
PMID: 35359982
Free PMC article.
Item in Clipboard
Preferential Expansion of Human CD34+CD133+CD90+ Hematopoietic Stem Cells Enhances Gene-Modified Cell Frequency for Gene Therapy.
Christopher AC, Venkatesan V, Karuppusamy KV, Srinivasan S, Babu P, Azhagiri MKK, Chambayil K, Bagchi A, Rajendiran V, Ravi NS, Kumar S, Marepally SK, Mohankumar KM, Srivastava A, Velayudhan SR, Thangavel S.
Christopher AC, et al. Among authors: karuppusamy kv.
Hum Gene Ther. 2022 Feb;33(3-4):188-201. doi: 10.1089/hum.2021.089. Epub 2022 Jan 7.
Hum Gene Ther. 2022.
PMID: 34486377
Item in Clipboard
The Strategies and Challenges of CCR5 Gene Editing in Hematopoietic Stem and Progenitor Cells for the Treatment of HIV.
Karuppusamy KV, Babu P, Thangavel S.
Karuppusamy KV, et al.
Stem Cell Rev Rep. 2021 Oct;17(5):1607-1618. doi: 10.1007/s12015-021-10145-7. Epub 2021 Mar 31.
Stem Cell Rev Rep. 2021.
PMID: 33788143
Review.
Item in Clipboard
Cite
Cite